Arteris (AIP) Director Raza Saiyed Atiq Sells Shares

What Happened
Raza Saiyed Atiq, a director of Arteris, sold a total of 70,000 shares in open-market transactions on August 3, 2026, generating aggregate proceeds of approximately $2,100,580. The sales were reported in three tranches: 5,921 shares at a $28.78 weighted-average ($170,386); 36,827 shares at a $29.99 weighted-average ($1,104,434); and 27,252 shares at a $30.30 weighted-average ($825,760). These were dispositions (sales), not purchases.

Key Details

• Transaction date: August 3, 2026 (filed August 5, 2026). No late filing is indicated in the provided data.
• Sale breakdown:
  • 5,921 shares — weighted avg price $28.78; sale-price range reported $28.17–$29.11 (F2). Proceeds ≈ $170,386.
  • 36,827 shares — weighted avg price $29.99; sale-price range reported $29.17–$30.16 (F4). Proceeds ≈ $1,104,434.
  • 27,252 shares — weighted avg price $30.30; sale-price range reported $30.17–$30.61 (F5). Proceeds ≈ $825,760.
• Total: 70,000 shares sold for about $2,100,580.
• Footnotes of note:
  • F1: Transactions executed pursuant to a 10b5-1 trading plan adopted November 7, 2025.
  • F3: Shares were held by the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust (Reporting Person is trustee).
  • F2/F4/F5: Weighted-average prices reflect multiple trades at prices within the stated ranges; detailed per-price breakdowns are available on request.
• Shares owned after the transaction: not provided in the information supplied; see the full Form 4 for post-transaction holdings.

Context

• These sales were made under a pre-established 10b5-1 plan, which typically means trades were scheduled in advance and executed according to that plan rather than timed opportunistically.
• Sales by directors are common and do not, by themselves, indicate the director's view on the company's prospects.